Injection therapy for bleeding peptic ulcers

J. Y W Lau; Joseph Leung

Injection therapy for bleeding peptic ulcers

Research output: Contribution to journal › Article › peer-review

Abstract

In the treatment of bleeding peptic ulcers, the concept of dual therapy combining a second modality to epinephrine injection is theoretically appealing. The addition of a sclerosant has not been shown to be beneficial. Early evidence suggests that adding contact thermocoagulation or a thrombogenic agent improves patient outcome.

Original language	English (US)
Pages (from-to)	575-591
Number of pages	17
Journal	Gastrointestinal Endoscopy Clinics of North America
Volume	7
Issue number	4
State	Published - 1997
Externally published	Yes

ASJC Scopus subject areas

Surgery
Gastroenterology

Cite this

@article{ad1895581dde422b9d5709508f07f6aa,

title = "Injection therapy for bleeding peptic ulcers",

abstract = "In the treatment of bleeding peptic ulcers, the concept of dual therapy combining a second modality to epinephrine injection is theoretically appealing. The addition of a sclerosant has not been shown to be beneficial. Early evidence suggests that adding contact thermocoagulation or a thrombogenic agent improves patient outcome.",

author = "Lau, {J. Y W} and Joseph Leung",

year = "1997",

language = "English (US)",

volume = "7",

pages = "575--591",

journal = "Gastrointestinal Endoscopy Clinics of North America",

issn = "1052-5157",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Injection therapy for bleeding peptic ulcers

AU - Lau, J. Y W

AU - Leung, Joseph

PY - 1997

Y1 - 1997

N2 - In the treatment of bleeding peptic ulcers, the concept of dual therapy combining a second modality to epinephrine injection is theoretically appealing. The addition of a sclerosant has not been shown to be beneficial. Early evidence suggests that adding contact thermocoagulation or a thrombogenic agent improves patient outcome.

AB - In the treatment of bleeding peptic ulcers, the concept of dual therapy combining a second modality to epinephrine injection is theoretically appealing. The addition of a sclerosant has not been shown to be beneficial. Early evidence suggests that adding contact thermocoagulation or a thrombogenic agent improves patient outcome.

UR - http://www.scopus.com/inward/record.url?scp=0030733879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030733879&partnerID=8YFLogxK

M3 - Article

C2 - 9376952

AN - SCOPUS:0030733879

VL - 7

SP - 575

EP - 591

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 4

ER -

Injection therapy for bleeding peptic ulcers

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this